Allergan Unredacted Emails To Refute Ackman Claims
The voluminous number of emails and official documents showing private conversations between Allergan, Inc. (NYSE:AGN) executives and outside consultants, to be public in court tomorrow, were unredacted by Allergan with the goal to refute claims by Pershing Square’s Bill Ackman, a source with direct involvement in the situation said.
Allergan emails do not put out false information
Allergan, Inc. (NYSE:AGN) made the decision to release the . . .
This content is exclusively for paying members of ValueWalk Premium Gain Exclusive Access to the Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with ValueWalk Premium Get Started Now with a FREE 7-Day Trial 🔻 If you are a current ValueWalk Premium member and are having an account error please clear cache and cookies. If that does not work, email [email protected] or click Chat.
|
